Melissa A Gilbert1, Nancy B Spinner1. 1. Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
Abstract
PURPOSE OF REVIEW: We review the genetics of the autosomal dominant, multi-system disorder, Alagille syndrome and provide a summary on how current functional models and emerging biotechnologies are equipped to guide scientists towards novel therapies. The importance of haploinsufficiency as a disease mechanism will be underscored throughout this discussion. RECENT FINDINGS: Alagille syndrome, a human disorder affecting the liver, heart, vasculature, kidney, and other systems, is caused by mutations in the Notch signaling pathway ligand, Jagged1 (JAG1) or the receptor, NOTCH2. Current advances in animal modeling, in vitro cell culture, and human induced pluripotent stem cells, provide new opportunities in which to study disease mechanisms and manifestations. SUMMARY: We anticipate that the availability of innovative functional models will allow scientists to test new gene therapies or small molecule treatments in physiologically-relevant systems. With these advances, we look forward to the development of new methods to help Alagille syndrome patients.
PURPOSE OF REVIEW: We review the genetics of the autosomal dominant, multi-system disorder, Alagille syndrome and provide a summary on how current functional models and emerging biotechnologies are equipped to guide scientists towards novel therapies. The importance of haploinsufficiency as a disease mechanism will be underscored throughout this discussion. RECENT FINDINGS: Alagille syndrome, a human disorder affecting the liver, heart, vasculature, kidney, and other systems, is caused by mutations in the Notch signaling pathway ligand, Jagged1 (JAG1) or the receptor, NOTCH2. Current advances in animal modeling, in vitro cell culture, and human induced pluripotent stem cells, provide new opportunities in which to study disease mechanisms and manifestations. SUMMARY: We anticipate that the availability of innovative functional models will allow scientists to test new gene therapies or small molecule treatments in physiologically-relevant systems. With these advances, we look forward to the development of new methods to help Alagille syndrome patients.
Authors: Ryan McDaniell; Daniel M Warthen; Pedro A Sanchez-Lara; Athma Pai; Ian D Krantz; David A Piccoli; Nancy B Spinner Journal: Am J Hum Genet Date: 2006-05-10 Impact factor: 11.025
Authors: Matthew J Ryan; Christina Bales; Anthony Nelson; Dorian M Gonzalez; Lara Underkoffler; Michelle Segalov; Jeanne Wilson-Rawls; Susan E Cole; Jennifer L Moran; Pierre Russo; Nancy B Spinner; Kenro Kusumi; Kathleen M Loomes Journal: Hepatology Date: 2008-12 Impact factor: 17.425
Authors: Ana M Crane; Philipp Kramer; Jacquelin H Bui; Wook Joon Chung; Xuan Shirley Li; Manuel L Gonzalez-Garay; Finn Hawkins; Wei Liao; Daniela Mora; Sangbum Choi; Jianbin Wang; Helena C Sun; David E Paschon; Dmitry Y Guschin; Philip D Gregory; Darrell N Kotton; Michael C Holmes; Eric J Sorscher; Brian R Davis Journal: Stem Cell Reports Date: 2015-03-12 Impact factor: 7.765
Authors: Pablo Perez-Pinera; D Dewran Kocak; Christopher M Vockley; Andrew F Adler; Ami M Kabadi; Lauren R Polstein; Pratiksha I Thakore; Katherine A Glass; David G Ousterout; Kam W Leong; Farshid Guilak; Gregory E Crawford; Timothy E Reddy; Charles A Gersbach Journal: Nat Methods Date: 2013-07-25 Impact factor: 28.547
Authors: Joshua M Adams; Kari A Huppert; Eumenia C Castro; Mario F Lopez; Nima Niknejad; Sanjay Subramanian; Neda Zarrin-Khameh; Milton J Finegold; Stacey S Huppert; Hamed Jafar-Nejad Journal: Hepatology Date: 2020-01-24 Impact factor: 17.425
Authors: Melissa A Gilbert; Robert C Bauer; Ramakrishnan Rajagopalan; Christopher M Grochowski; Grace Chao; Deborah McEldrew; James A Nassur; Elizabeth B Rand; Bryan L Krock; Binita M Kamath; Ian D Krantz; David A Piccoli; Kathleen M Loomes; Nancy B Spinner Journal: Hum Mutat Date: 2019-08-26 Impact factor: 4.878
Authors: Ellen K Gagliani; Lisa M Gutzwiller; Yi Kuang; Yoshinobu Odaka; Phillipp Hoffmeister; Stefanie Hauff; Aleksandra Turkiewicz; Emily Harding-Theobald; Patrick J Dolph; Tilman Borggrefe; Franz Oswald; Brian Gebelein; Rhett A Kovall Journal: PLoS Genet Date: 2022-08-11 Impact factor: 6.020
Authors: Jeremy M Sullivan; William W Motley; Janel O Johnson; William H Aisenberg; Katherine L Marshall; Katy Es Barwick; Lingling Kong; Jennifer S Huh; Pamela C Saavedra-Rivera; Meriel M McEntagart; Marie-Helene Marion; Lucy A Hicklin; Hamid Modarres; Emma L Baple; Mohamed H Farah; Aamir R Zuberi; Cathleen M Lutz; Rachelle Gaudet; Bryan J Traynor; Andrew H Crosby; Charlotte J Sumner Journal: J Clin Invest Date: 2020-03-02 Impact factor: 14.808
Authors: Archana Kamalakar; Jay M McKinney; Daniel Salinas Duron; Angelica M Amanso; Samir A Ballestas; Hicham Drissi; Nick J Willett; Pallavi Bhattaram; Andrés J García; Levi B Wood; Steven L Goudy Journal: Bone Date: 2020-09-25 Impact factor: 4.626